股
这个票严重低估,账面现金是今天市值的三倍
而且平台的技术授权最近收到500万美金,这还不包括利用该平台技术商业话的 抽成
太便宜了查看全文
产业链观察2021-12-07 00:02
药闻▶2021 年 12 月 6 日,-开发新型、可控的癌症细胞免疫疗法的领导者$Bellicum制药(BLCM)$宣布了其正在进行的 1/2 期 GoCAR-T 的积极中期数据临床试验,包括在 BPX-601 临床试验中治疗的第一组 mCRPC 患者中确认的部分反应 (PR)。
Bellicum 还与两家生物技术专业投资基金签订...查看全文
牛唐2021-02-17 11:21
医药板块速评(2021.02.10)
1、逆向并购概念股继续火爆,还有哪些值得布局?$Bellicum制药(BLCM)$
2、$Galapagos(GLPG)$ 现金牛暴跌,是否值得抄底?
3、又一家有催化剂临近的SPAC公司,是否值得入手?
$荔枝(LIZI)$查看全文
Replix锐璞美股2021-01-29 21:25
$Catabasis制药(CATB)$ $Bellicum制药(BLCM)$ $Phio Pharmaceuticals(PHIO)$ 相继爆炸!查看全文
$Bellicum制药(BLCM)$ 8-K - Current report Filed: 2017-05-15 AccNo: 0001193125-17-170747 Size: 69 KBItem 1.01: Entry into a Material Definitive AgreementItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory ...
$Bellicum制药(BLCM)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2017-05-08 AccNo: 0001358403-17-000073 Size: 3 MB 网页链接
$Bellicum制药(BLCM)$ 8-K - Current report Filed: 2017-05-08 AccNo: 0001358403-17-000071 Size: 180 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$Bellicum制药(BLCM)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2017-05-08 AccNo: 0001358403-17-000073 Size: 3 MB 网页链接
$Bellicum制药(BLCM)$ 8-K - Current report Filed: 2017-05-08 AccNo: 0001358403-17-000071 Size: 180 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$Bellicum制药(BLCM)$ DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material Filed: 2017-04-26 AccNo: 0001358403-17-000062 Size: 113 KB 网页链接
$Bellicum制药(BLCM)$ DEF 14A - Other definitive proxy statements Filed: 2017-04-26 AccNo: 0001358403-17-000061 Size: 1 MB 网页链接
$Bellicum制药(BLCM)$ SC 13G - Statement of acquisition of beneficial ownership by individuals Filed: 2017-04-11 AccNo: 0001144204-17-020038 Size: 89 KB 网页链接
$Bellicum制药(BLCM)$ 内部交易: 2017-03-24,10% Owner,BAKER BROS. ADVISORS LP ,买入,166666普通股, $12.00
$Bellicum制药(BLCM)$ SC 13D/A [Amend] - General statement of acquisition of beneficial ownership Filed: 2017-03-28 AccNo: 0001144204-17-017097 Size: 99 KB 网页链接